Registration is now open in Bahia for people interested in participating in the new research on the Covid-19 vaccine developed by researchers from the University of Oxford in partnership with the Swedish laboratory AstraZeneca.
- See the graph of cases and deaths in Salvador since the beginning of the pandemic
To participate, you must be over 18 years old. Registrations are made through the internet. In the document, the interested party must fill out, among others, data such as name, CPF, address, profession and also if they have already done any test or exam for Covid-19.
The number of volunteers that will be recruited has not yet been announced, nor when this stage of the research will take place.
The Oxford vaccine is applied to volunteers from Salvador, at São Rafael Hospital.
Earlier this month, the vaccine stopped testing after an adverse reaction in a patient in the UK.
On the 15th of this month, Anvisa authorized the expansion of the number of volunteers to test the Oxford vaccine in Brazil.
Registration for those interested in participating in Covid-19 vaccine research is open at BA – Photo: University of Oxford via AP
The Government of Bahia has signed protocols to test other vaccines. Russia, Sputink V, is scheduled to arrive in November. About 500 Bahian volunteers should receive the vaccine. If it obtains all authorizations, and if it is approved by the National Health Surveillance Agency (Anvisa), the immunizer can be marketed in the country through Bahia. The forecast is that around 50 million doses are destined for Brazil.
The state also tested the vaccine produced with German biotechnology by the American company Pfizer. Testing ended this month. The results, however, have not yet been released.
A thousand volunteers participated in the vaccine application test. Initially, there would be 500 people, but the number was expanded. In addition to Salvador, the Pfizer vaccine was also tested in São Paulo.
Recently, it was announced that the vaccine against Covid-19 developed by the conglomerate of companies Johnson & Johnson, in a partnership between the United States of America and Belgium, will be tested in Salvador. Activities should start in October.
See more state news on G1 Bahia.